November 05, 2026 5:00am EST Download as PDF Related Documents Audio Earnings Webcast Earnings Presentation PDF 10-Q Filing PDF HTML XBRL ZIP HTML WAYNE, Pa., Nov. 5, 2026 /PRNewswire/ -- Ecovyst Inc. (NYSE: ECVT) ("Ecovyst" or the "Company"), a…
November 05, 2026 5:00am EST Download as PDF
Related Documents
Audio
Earnings Webcast
Earnings Presentation
PDF
10-Q Filing
PDF
HTML
XBRL
ZIP
HTML
WAYNE, Pa., Nov. 5, 2026 /PRNewswire/ -- Ecovyst Inc. (NYSE: ECVT) ("Ecovyst" or the "Company"), a leading provider of regenerated sulfuric acid, virgin sulfuric acid, and sulfur dioxide and related derivatives, today reported results for the third quarter ended September 30, 2026.

On December 31, 2025, the Company completed the sale of its Advanced Materials & Catalysts business, which included the Company's investment in affiliated companies, Zeolyst International and Zeolyst C.V. Financial results of the divested Advanced Materials & Catalysts business are reported in discontinued operations in the financial statements for all periods presented.
Reported results for the third quarter of 2026 included the Calabrian sulfur dioxide and related derivatives business acquired on June 30, 2026.
Third Quarter 2026 Results & Highlights from Continuing Operations
- Sales grew 51% to $308.6 million, an increase of $103.7 million, from $204.9 million in the third quarter of 2025
- Net income of $18.4 million, compared to $0.2 million in the year-ago quarter, with a net income margin of 6.0% and diluted net income per share of $0.17
- Adjusted Net Income1 was $25.3 million, compared to $21.5 million in the year-ago quarter, with Adjusted Diluted Income per share of $0.23
- Adjusted EBITDA1 of $61.2 million, an increase of $3.7 million, or 6% compared to $57.5 million in the third quarter of 2025
- Cash flow from operating activities was $80.7 million for the nine months ended September 30, 2026, compared to $77.0 million for the nine months ended September 30, 2025. Adjusted Free Cash Flow1 was $32.4 million for the nine months ended September 30, 2026, compared to $42.4 million for the nine months ended September 30, 2025
1 Refer to the Presentation of Non-GAAP Financial Measures section below for additional information.
"Ecovyst delivered another strong quarter, with third quarter 2026 Adjusted EBITDA of $61 million, up over 6% compared to the year-ago quarter, and above the high end of our guidance range," said Kurt J. Bitting, Ecovyst's Chief Executive Officer. "Strong refining margins and increased export demand drove year-over-year growth in regenerated sulfuric acid volumes and sales. Virgin sulfuric acid sales also increased, benefiting from solid mining demand, stable demand across industrial applications and positive pricing fundamentals. These results also reflect our first full quarter of owning Calabrian, which we acquired on June 30, 2026. Calabrian's third quarter performance was consistent with our investment thesis, integration is underway, and we remain on track to capture anticipated synergies," added Bitting.
"Given current refining economics, we anticipate high refinery utilization through year-end and we expect demand across our portfolio to remain healthy for the rest of the year. We are again raising our full-year Adjusted EBITDA guidance to a range of $208 million to $212 million, reflecting strong momentum through the first nine months of the year and the shift of a turnaround from the fourth quarter into early 2027," Bitting said. "We remain flexible in how we allocate capital while prioritizing stockholder value. This includes pursuing organic and inorganic growth opportunities and returning capital to stockholders through share repurchases. We repurchased $2.7 million of our common stock in the third quarter and intend to repurchase up to a total of $20 million in the second half of 2026," Bitting added.
Review of Business Results
Third quarter 2026 sales were $308.6 million, up $103.7 million or 51%, compared to $204.9 million in the third quarter of 2025. The increase in sales reflects higher sales volume and pricing compared to the prior year quarter, as well as the results for the Calabrian business acquired June 30, 2026. Average selling prices were higher primarily due to the pass-through effect of higher sulfur costs of approximately $67 million and favorable contractual pricing for regenerated sulfuric acid. The increase in sales volume was driven by higher sales of regenerated sulfuric acid from strong demand and less customer downtime, along with the contribution of sales volume from the Calabrian business, compared to the prior year quarter. Third quarter 2026 Adjusted EBITDA was $61.2 million, up $3.7 million or 6%, compared to $57.5 million in the third quarter of 2025, with the increase primarily driven by higher sales volume and favorable net pricing, partially offset by higher manufacturing costs, general inflation and higher transportation costs.
Cash Flows and Balance Sheet
Cash flows from operating activities for continuing operations were $80.7 million for the nine months ended September 30, 2026, compared to $77.0 million for the nine months ended September 30, 2025. The increase was primarily driven by higher earnings exclusive of non-cash expenses.
As of September 30, 2026, the Company had cash and cash equivalents of $71.2 million. Total gross debt was $497.1 million and availability under the Asset-Based Lending ("ABL") facility was $95.8 million, after giving effect to $2.2 million of outstanding letters of credit and with no revolving credit facility borrowings outstanding. Total cash and cash equivalents of $71.2 million plus the $95.8 million of availability under the ABL facility provided for total available liquidity of $167.0 million.
As of September 30, 2026, the Net Debt to Net Income Ratio was 9.7x and the Net Debt Leverage Ratio was 2.1x. The increase in the Net Debt Leverage Ratio from 1.2x at December 31, 2025 is due to the $100 million increase in the term loan associated with the acquisition of the Calabrian business offset by only one quarter of Calabrian-related Adjusted EBITDA reflected in the trailing twelve-month period.
Revised 2026 Financial Outlook
For the remainder of 2026, we expect demand for regenerated and virgin sulfuric acid to remain positive. We believe that high refinery utilization and strong alkylate demand will continue to support sales of regenerated sulfuric acid. For virgin sulfuric acid, we expect ongoing growth in demand for copper mining applications will continue to benefit sales. However, we remain cautious about the potential for unplanned outages with our refining customers. In addition, a significant decrease in the price of sulfur could drive short-term customer destocking. For sales of sulfur dioxide in our Calabrian business, we expect that high operating rates for Canadian gold mines will continue in the fourth quarter.
Given strong financial performance over the first nine months of the year, the Company is further revising its 2026 guidance as follows:
- Sales1 of $1,050 million to $1,070 million (change from $1,020 million to $1,060 million)
- Adjusted EBITDA2 of approximately $208 million to $212 million (change from $195 million to $207 million), including an impact from Calabrian in the fourth quarter of $5 million to $6 million
- Adjusted Free Cash Flow2 of $50 million to $60 million (change from $45 million to $55 million)
- Capital expenditures of $90 million to $95 million (change from $85 million to $95 million)
- Interest expense of $19 million to $21 million (change from $18 million to $22 million)
- Depreciation & Amortization of $84 million to $88 million (change from $80 million to $84 million)
- Effective tax rate in the mid 20% range
- Adjusted Net Income2 of $70 million to $85 million (change from $65 million to $85 million), with Adjusted Diluted Income per share2 of $0.63 to $0.77 (change from $0.58 to $0.72)
1Sales outlook for 2026 assumes higher average sulfur prices compared to 2025 and higher projected pass-through of sulfur costs of approximately $220 million.
2In reliance upon the unreasonable efforts exemption provided under Item 10(e)(1)(i)(B) of Regulation S-K, the Company is not able to provide a reconciliation of its non-GAAP financial guidance to the corresponding GAAP measures without unreasonable effort because of the inherent difficulty in forecasting and quantifying certain amounts necessary for such a reconciliation such as certain non-cash, nonrecurring or other items that are included in net income and net cash provided by operating activities as well as the related tax impacts of these items and asset dispositions / acquisitions and changes in foreign currency exchange rates that are included in cash flow, due to the uncertainty and variability of the nature and amount of these future charges and costs. Because this information is uncertain, the Company is unable to address the probable significance of the unavailable information, which could be material to future results.
Stock Repurchase
In April 2022, the Company's Board of Directors approved a stock repurchase program authorizing the repurchase of up to $450 million of the Company's outstanding common stock. In October 2025, the Company's Board of Directors approved the removal of the expiration date of the stock repurchase program. As of September 30, 2026, $143.8 million was available for stock repurchases under the program.
During the third quarter of 2026, the Company repurchased 263,719 shares of its common stock on the open market at an average price of $10.25 per share, for a total cost of $2.7 million.
During the third quarter of 2025, the Company repurchased 610,212 shares of its common stock on the open market at an average price of $9.06 per share, for a total cost of $5.5 million.
For possible future repurchases, the actual timing, number, and nature of shares repurchased will depend on a variety of factors, including stock price, trading volume, and general business and market conditions and may be conducted through negotiated transactions, open market repurchases or other means, including through Rule 10b-18 and Rule 10b5-1 trading plans or accelerated stock repurchases. The repurchase program does not obligate the Company to acquire any number of shares in any specific period, or at all, and the repurchase program may be amended, suspended or discontinued at any time at the Company's discretion.
Conference Call and Webcast Details
On Thursday, November 5, 2026, Ecovyst management will review the third quarter 2026 results during a conference call and audio-only webcast scheduled for 11:00 a.m. Eastern Time.
Conference Call: Investors may listen to the conference call live via telephone by dialing 1 (833) 461-5787 (USA Toll-Free) or 1 (585) 542-9983 (international) and use the participant code ECVTQ326. Investors may also join via live webcast through https://events.q4inc.com/attendee/344343271
. This link may also be accessed at https://investor.ecovyst.com
. A replay of the conference call/webcast will be made available at https://investor.ecovyst.com/events-presentations
.
Investor Contact:
Gene Shiels
(484) 617-1225
[email protected]
About Ecovyst Inc.
Ecovyst Inc. and subsidiaries is a leading provider of regenerated sulfuric acid, virgin sulfuric acid and sulfur dioxide and related derivatives, which we believe are essential to our customers' operations and processes.
Our family of virgin sulfuric acid products, regenerated sulfuric acid and related derivatives serve a wide range of industrial applications. We are a leading provider of regenerated sulfuric acid to the North American refining industry for the production of alkylate, an essential gasoline component for lowering vapor pressure and increasing octane to meet stringent gasoline specifications and fuel efficiency standards. We are a leading North American producer of high quality and high strength virgin sulfuric acid for industrial and mining applications. Through our Calabrian business, we are also a leading producer of sulfur dioxide and related derivatives in North America, serving key end uses including mining, water treatment and specialty chemical production. We also provide chemical waste handling and treatment services, as well as ex-situ catalyst activation services for the refining and petrochemical industry.